AU2019901050A0 - A salt and crystal form of a FAK inhibitor - Google Patents

A salt and crystal form of a FAK inhibitor

Info

Publication number
AU2019901050A0
AU2019901050A0 AU2019901050A AU2019901050A AU2019901050A0 AU 2019901050 A0 AU2019901050 A0 AU 2019901050A0 AU 2019901050 A AU2019901050 A AU 2019901050A AU 2019901050 A AU2019901050 A AU 2019901050A AU 2019901050 A0 AU2019901050 A0 AU 2019901050A0
Authority
AU
Australia
Prior art keywords
salt
crystal form
fak inhibitor
fak
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019901050A
Inventor
Christopher Burns
John Lambert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amplia Therapeutics Ltd
Original Assignee
Amplia Therapeutics Ltd
Filing date
Publication date
Application filed by Amplia Therapeutics Ltd filed Critical Amplia Therapeutics Ltd
Publication of AU2019901050A0 publication Critical patent/AU2019901050A0/en
Priority to CA3130727A priority Critical patent/CA3130727A1/en
Priority to US17/598,187 priority patent/US20220340540A1/en
Priority to KR1020217033285A priority patent/KR20210145175A/en
Priority to AU2020245902A priority patent/AU2020245902A1/en
Priority to PCT/AU2020/050292 priority patent/WO2020191448A1/en
Priority to EP20778576.7A priority patent/EP3947361A4/en
Priority to CN202080023710.XA priority patent/CN113646303A/en
Priority to JP2021560276A priority patent/JP2022528747A/en
Priority to SG11202109438T priority patent/SG11202109438TA/en
Abandoned legal-status Critical Current

Links

AU2019901050A 2019-03-28 2019-03-28 A salt and crystal form of a FAK inhibitor Abandoned AU2019901050A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA3130727A CA3130727A1 (en) 2019-03-28 2020-03-27 A salt and crystal form of a fak inhibitor
US17/598,187 US20220340540A1 (en) 2019-03-28 2020-03-27 A salt and crystal form of a fak inhibitor
KR1020217033285A KR20210145175A (en) 2019-03-28 2020-03-27 Salts and crystalline forms of FAK inhibitors
AU2020245902A AU2020245902A1 (en) 2019-03-28 2020-03-27 A salt and crystal form of a FAK inhibitor
PCT/AU2020/050292 WO2020191448A1 (en) 2019-03-28 2020-03-27 A salt and crystal form of a fak inhibitor
EP20778576.7A EP3947361A4 (en) 2019-03-28 2020-03-27 A salt and crystal form of a fak inhibitor
CN202080023710.XA CN113646303A (en) 2019-03-28 2020-03-27 Salts and crystalline forms of FAK inhibitors
JP2021560276A JP2022528747A (en) 2019-03-28 2020-03-27 FAK inhibitor salt and crystalline form
SG11202109438T SG11202109438TA (en) 2019-03-28 2020-03-27 A salt and crystal form of a fak inhibitor

Publications (1)

Publication Number Publication Date
AU2019901050A0 true AU2019901050A0 (en) 2019-04-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP3746075A4 (en) Gcn2 inhibitors and uses thereof
EP3746071A4 (en) Gcn2 inhibitors and uses thereof
EP3825309A4 (en) Salt of lsd1 inhibitor and a polymorph thereof
EP3628007A4 (en) Novel salts and crystals
EP3982949A4 (en) Inhibitors of sarm1
EP3980011A4 (en) Inhibitors of sarm1
EP3763713A4 (en) Crystal form and salt form of pyridoimidazole compound and preparation method therefor
EP4011881A4 (en) Crystalline form of atr inhibitor and use thereof
EP3725786A4 (en) Crystal form and salt form of tgf-bri inhibitor and preparation method therefor
EP3947361A4 (en) A salt and crystal form of a fak inhibitor
EP4063366A4 (en) Crystal form of nucleoprotein inhibitor and use thereof
EP3919493A4 (en) Crystal of diarylthiohydantoin compound
EP3981771A4 (en) Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof
AU2019901050A0 (en) A salt and crystal form of a FAK inhibitor
EP3601286A4 (en) Novel crystal forms of a pol1 inhibitor
EP3725791A4 (en) Salt serving as akt inhibitor and crystal thereof
EP3498704A4 (en) Crystal of dpp-iv long-acting inhibitor and salt thereof
EP3896063A4 (en) Salt of syk inhibitor and crystalline form thereof
EP3837268A4 (en) Salts of compounds and crystals thereof
EP4027993A4 (en) Cyclooxygenase-2 inhibitors and uses thereof
EP3854797A4 (en) Crystal form of tri-cycle compound and application thereof
EP3936189A4 (en) Salt of pentacyclic compound and crystals thereof
EP3924335A4 (en) Anti-fibrotic neu3 inhibitor compounds and methods of use
EP3774733A4 (en) Novel salt forms of urat-1 inhibitors
EP3762401A4 (en) Combination of depletes tregs and a checkpoint inhibitor